Provider Opinions Regarding Expanding Access to Hormonal Contraception in Pharmacies

Rafie, Sally; Kelly, Sanaz; Gray, Erika K.; Wong, Megan; Gibbs, Susannah E.; Harper, Cynthia C.

doi:10.1016/j.whi.2015.09.006

Cited by 41 publications

(38 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A validated tool was not available, therefore the researchers developed the questions pragmatically to meet the study aims, considering previously reported concerns, barriers and opportunities of expanding contraception provision in pharmacies 18. The questionnaire included questions with fixed and rating scale responses, with opportunities for additional comments to be made as free-text responses.…”

Section: Methodsmentioning

confidence: 99%

“…A study of nearly 500 contraception providers in the United States showed almost three-quarters supported pharmacists initiating combined hormonal contraception (CHC), progestogen-only pills (POPs) and injectable contraception (IC),18 and a UK study of SRH clinicians showed that >90% felt positively about pharmacists initiating POP at the time of EC 19…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Sexual and reproductive healthcare providers’ opinions on expansion of pharmacy-led provision of contraception

Boog

Chen

Cameron

2019

BMJ Sex Reprod Health

View full text Add to dashboard Cite

IntroductionReduced funding to contraceptive services in the UK is resulting in restricted access for women. Pharmacists are already embedded in sexual and reproductive health (SRH) care in the UK and could provide an alternative way for women to access contraception. The aim of this study was to determine the views of UK contraception providers about community pharmacist-led contraception provision.MethodsAn anonymous questionnaire was distributed to healthcare professionals at two UK SRH events, asking respondents about: (1) the use of patient group directions (PGDs) for pharmacist provision of oral contraception (OC); (2) the sale of OC as a pharmacy medicine or general sales list medicine; (3) the perceived impact of pharmacy provision of OC on broader SRH outcomes; and (4) if other contraceptive methods should be provided in pharmacies.ResultsOf 240 questionnaires distributed, 174 (72.5%) were returned. Respondents largely supported pharmacy-led provision of all non-uterine methods of contraception, excluding the contraceptive implant. Provision of the progestogen-only pill by PGD was most strongly supported (78% supported initiation). Respondents felt that the use of bridging (temporary) contraception would improve (103/144, 71.5%), use of effective contraception would increase (81/141, 57.4%), and unintended pregnancies would decline (71/130, 54.6%); but that use of long-acting reversible contraception would decrease (86/143, 60.1%). Perceived barriers included pharmacists’ capacity and competency to provide a full contraception consultation, safeguarding concerns, and women having to pay for contraception.ConclusionsUK SRH providers were largely supportive of community pharmacy-led provision of contraception, with training and referral pathways being required to support contraception delivery by pharmacists.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Sexual and reproductive healthcare providers’ opinions on expansion of pharmacy-led provision of contraception

Boog

Chen

Cameron

2019

BMJ Sex Reprod Health

View full text Add to dashboard Cite

show abstract

“…Pharmacists play an important role in the provision of reproductive health care, including prescribing hormonal contraception and emergency contraception in some states. [1][2][3][4][5] However, pharmacists have limited involvement in abortion care, despite the growing use of medications to induce termination of early pregnancy, known as medical or medication abortion ( Figure 1). Federal regulations require that mifepristone, the principal drug used in medication abortion, be dispensed by a certified provider in an outpatient clinic or hospital and not by prescription in a pharmacy.…”

mentioning

confidence: 99%

Medication abortion: Potential for improved patient access through pharmacies

Raifman¹,

Orlando²,

Rafie³

et al. 2018

Journal of the American Pharmacists Association

Self Cite

View full text Add to dashboard Cite

show abstract

“…20 Health care providers have supported increased access to hormonal contraception as an important public health service and have suggested that pharmacy access could be accomplished through pharmacist education and training. 21 With such support for pharmacistinitiated contraceptives from patients and physicians, it is important to understand pharmacists' comfort and knowledge about this new prescribing authority as it expands across the United States.…”

mentioning

confidence: 99%

Pharmacists’ comfort level and knowledge about prescribing hormonal contraception in a supermarket chain pharmacy

Lio¹,

Remines²,

Nadpara³

et al. 2018

Journal of the American Pharmacists Association

View full text Add to dashboard Cite

show abstract

Provider Opinions Regarding Expanding Access to Hormonal Contraception in Pharmacies

Cited by 41 publications

References 21 publications

Sexual and reproductive healthcare providers’ opinions on expansion of pharmacy-led provision of contraception

Sexual and reproductive healthcare providers’ opinions on expansion of pharmacy-led provision of contraception

Medication abortion: Potential for improved patient access through pharmacies

Pharmacists’ comfort level and knowledge about prescribing hormonal contraception in a supermarket chain pharmacy

Contact Info

Product

Resources

About